This, for instance, applies to the mutation clusters targeting known cancer genes kinetochore localized astrin (SPAG5) binding protein (KNSTRN) and BCL2-like 12 (BCL2L12), each affecting 4%–5% of melanoma tumors. The gene discussed is KNSTRN; the disease is cancer.